SIRONAX
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms underlying age-related degenerative diseases including regulated cell death, neuroprotective pathways, and neuroinflammation. They aim to shift the treatment paradigm for age-related degenerative disease to improve the lives of millions of patients and their families around the world. Sironax was founded in 2017 and is based in Beijing, China.
SIRONAX
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2017-09-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.sironax.com.cn
Total Employee:
101+
Status:
Active
Contact:
86-10-80765868
Total Funding:
301 M USD
Technology used in webpage:
IPv6
Current Employees Featured
Xiaodong Wang Co-Founder & Chairman @ Sironax
Co-Founder & Chairman
Zhiyuan Zhang Co-Founder, Senior Scientific Advisor, and CSO @ Sironax
Co-Founder, Senior Scientific Advisor, and CSO
2018-06-01
Aaron Ren CEO @ Sironax
CEO
Founder
Investors List
Temasek Holdings
Temasek Holdings investment in Series B - Sironax
Future Innovation Fund
Future Innovation Fund investment in Series B - Sironax
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Sironax
Superstring Capital
Superstring Capital investment in Series B - Sironax
F-Prime Capital
F-Prime Capital investment in Series B - Sironax
YF Capital
YF Capital investment in Series B - Sironax
Invus
Invus investment in Series B - Sironax
CBC Group
CBC Group investment in Series B - Sironax
K2 Venture Capital
K2 Venture Capital investment in Series B - Sironax
Gaorong Capital
Gaorong Capital investment in Series B - Sironax
Official Site Inspections
http://www.sironax.com.cn
- Host name: 156.225.111.22
- IP address: 156.225.111.22
- Location: Johannesburg South Africa
- Latitude: -26.2309
- Longitude: 28.0583
- Timezone: Africa/Johannesburg
- Postal: 2000
More informations about "Sironax"
SIRONAX
Aging is not a disease, but it is often accompanied by a complex array of chronic degenerative diseases. Sironax is committed to promoting healthier aging by targeting the underlying …See details»
Who we are - sironax.com.cn
Sironax is an emerging leader in the discovery and development of transformational therapies that address the root cause of age-related degenerative disease. Today, the majority of treatments …See details»
Sironax - Crunchbase Company Profile & Funding
Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases. The company is focusing on key mechanisms …See details»
Who we are - new.sironax.com.cn
Vitarelon, SIRONAX, Beijing Weitai Ruilong Biotechnology Co., Ltd. specializes in degenerative diseases, degenerative neurological diseases, Alzheimer's disease, and transformative therapiesSee details»
Keep updated - sironax.com.cn
Vitarelon, SIRONAX, Beijing Weitai Ruilong Biotechnology Co., Ltd. specializes in degenerative diseases, degenerative neurological diseases, Alzheimer's disease, and transformative therapiesSee details»
Sironax 2025 Company Profile: Valuation, Funding
Sironax General Information Description. Developer and researcher of pharmaceuticals for inflammatory and neurodegenerative diseases. The company researches apoptosis and other cell death pathways to develop quality …See details»
Sironax - LinkedIn
To date, Sironax's breakthrough pipeline contains multiple first-in-class and/or potentially best-in-class programs, among which 3 have entered into clinical stage. ... Beijing, Beijing 100000, CN ...See details»
Stay in touch - new.sironax.com.cn
SIRONAX BEIJING Building 2, Medical Technology Center, Zhongguancun Life Science Park, Changping, Beijing, China, 102206 +86-10-80765868 SIRONAX SHANGHAI Building 2, 1077 …See details»
Sironax Company Profile - Office Locations, Competitors ... - Craft
Sironax (维泰瑞隆) is a biotechnology company dedicated to the discovery and global development of new treatments for patients with age-related degenerative diseases. It …See details»
Join us - new.sironax.com.cn
Sironax was founded in 2017 to develop transformational therapies for age-related degenerative diseases. Sironax provides a broad platform for professional and personal development. We …See details»
Sironax Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Sironax Bolsters Fight against Degenerative Diseases with $200M Series B Also in Beijing, Sironax scooped up roughly $200 million in a Series B round of financing, led by Gaorong …See details»
Sironax(Beijing)Co.,Ltd. - China Daily
Sironax is an emerging leader in the discovery and development of transformational therapies that address the root cause of age-related degenerative disease. Today, the majority of treatments …See details»
Sironax Corporate Headquarters, Office Locations and Addresses
Sironax Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Sironax is headquartered in Beijing, 8-10/F, Building …See details»
Keep updated - cdnsource.sironax.com.cn
Sironax Announces Closing of $200M Series B Financing Aug 02, 2022 Learn more . About US. About Sironax. Leadership Team. Board of Directors. Our Science. Scientific Strategy. …See details»
Sironax - Overview, News & Similar companies | ZoomInfo.com
Jan 4, 2023 China-based Sironax is a clinical-stage biotechnology company dedicated to the discovery and global development of novel treatments for patients with age-related …See details»
Keep updated - sironax.com.cn
Sironax Announces Closing of $200M Series B Financing Aug 02, 2022 Learn more . About US. About Sironax. Leadership Team. Board of Directors. Our Science. Scientific Strategy. …See details»
Chinese biotech Sironax raises $200m for RIPK1 pipeline
4 days ago Sironax' lead RIPK1 drug, SIR0365, has completed two phase 1b studies including one looking at its potential as a treatment for severe hyperinflammation associated with …See details»
SIRONAX
Vitarelon, SIRONAX, Beijing Weitai Ruilong Biotechnology Co., Ltd. specializes in degenerative diseases, degenerative neurological diseases, Alzheimer's disease, and transformative therapiesSee details»
志在FIC：王晓东/张志远博士公司Sironax国内首次递交IND，RIPK1 …
Jul 28, 2021 2018年，北生所（NIBS）所长王晓东院士和原北生所资深研究员张志远博士正式共同创建维泰瑞隆（Sironax），目标是做一家全球性的专注于研发First-in-class化学药物的生物 …See details»
Join us - sironax.com.cn
Vitarelon, SIRONAX, Beijing Weitai Ruilong Biotechnology Co., Ltd. specializes in degenerative diseases, degenerative neurological diseases, Alzheimer's disease, and transformative …See details»